Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Recruiting 9Not yet recruiting 9Unknown 7Completed 7Active not recruiting 4Terminated 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 2Breast 1

Conditions

Neoplasms 2Pain 1Neuropathy, Painful 1Neuralgia 1Breast Neoplasms 1Agnosia 1

Interventions

pembrolizumab 438Carboplatin 321Nivolumab 293Cyclophosphamide 285Specimen Handling 257Paclitaxel 249Magnetic Resonance Spectroscopy 249Cisplatin 248Radiotherapy 218Dexamethasone 183Gemcitabine 177Biopsy 177durvalumab 169atezolizumab 149Doxorubicin 140Rituximab 138Lenalidomide 135Docetaxel 131Ipilimumab 130Bevacizumab 128Radiation 121Capecitabine 117Etoposide 116Oxaliplatin 114Fluorouracil 110Pemetrexed 109Radiosurgery 108fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Electroacupuncture × Clear all
NCT02754752 2026-04-15

Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
111 enrolled
Breast

Breast Neoplasms

NCT06340906 2026-02-13

Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

University of California, Irvine

Phase NA Active not recruiting
20 enrolled
Tumor-Agnostic

Neoplasms

NCT04917796 2026-01-30

ACT

Dana-Farber Cancer Institute

Phase NA Active not recruiting
255 enrolled

Neuropathy, Painful, Agnosia, Neuralgia, Pain

NCT05283577 2026-01-23

EAST

University of California, Irvine

Phase NA Active not recruiting
70 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡